Strengths highlight Catalent's robust biologics segment and expansive global infrastructure. Weaknesses underscore the ...

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry ...

Supply chain inefficiencies impact healthcare costs, quality of care and access to treatment. In fact, 93% of healthcare ...

With Johnson & Johnson (NYSE:JNJ) taking the lead, Big Pharma returned to dealmaking in H1 2024 even as the number of M&A ...

Cincinnati-based Cordental Group recently hired Len Schiavone to be its next CEO, PE Hub reported Sept. 19. Mr. Schiavone most recently served as COO of SENTA Partners, a management services ...

The first notable agency action in 2024 is the FTC’s Second Request in Novo Holding’s proposed $16.5 billion acquisition of Catalent, a life sciences contract manufacturer. 1 The agency’s interest in ...

CPHI Milan (8-10 October, 2024) announces the finalists for the upcoming CPHI Pharma Awards, which will be hosted on the event’s opening evening at the CPHI Celebration.The awards are a key feature of ...

List of Prominent Players in the Lipid Nanoparticles (LNPs) CDMO Market: In May 2022, ST Pharm launched its global mRNA ...

The Cell & Gene Therapy manufacturing Services market is driven by increasing investments in advanced therapies, rising ...

Our Bureau, Mumbai Wednesday, September 11, 2024, 16:40 Hrs [IST] CPHI Milan scheduled to be held from October 8-10, 2024 has announce ...